titlesubmit dateissue date
Now showing items 1-19 of 19
Assessment of quality indicators for acute myocardial infarction management in 28 countries and use of composite quality indicators for benchmarking.
Association Between Body Size Phenotypes and Subclinical Atherosclerosis.
CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions
Editor's Choice- Pathophysiology and therapy of myocardial ischaemia/reperfusion syndrome
Eplerenone in patients with myocardial infarction and "mid-range" ejection fraction: An analysis from the EPHESUS trial
Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality
Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience
In-Hospital Coronary Revascularization Rates and Post-Discharge Mortality Risk in Non-ST-Segment Elevation Acute Coronary Syndrome.
Infarct Size Reduction by Targeting Ischemic Injury: Back to Square One
Machine Learning Improves Cardiovascular Risk Definition for Young, Asymptomatic Individuals.
Metoprolol blunts the time-dependent progression of infarct size.
Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction
Myocardial Edema After Ischemia/Reperfusion Is Not Stable and Follows a Bimodal Pattern Imaging and Histological Tissue Characterization
Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute
New Cancer Diagnosis After Bleeding in Anticoagulated Patients With Atrial Fibrillation.
Predictors of all-cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry.
R2 prime (R2') magnetic resonance imaging for post-myocardial infarction intramyocardial haemorrhage quantification.
Regional variations in hospital management and post-discharge mortality in patients with non-ST-segment elevation acute coronary syndrome.
The RISK pathway and beyond